News & Updates

The real-world use of esketamine nasal spray is safe and has a safety profile consistent with that established in clinical studies and current product labeling, reports a US study. No new safety signals have been noted.

Both the Patient Healthcare Questionnaire (PHQ) and the Hospital Anxiety and Depression Scale (HADS) are useful for identifying stroke survivors with depression in Singaporean inpatient rehabilitation care settings, as shown in a study.

A slow-tempo music intervention falls short of reducing the duration and severity of delirium in older patients on mechanical ventilation, according to a study.

In the treatment of patients with major depressive disorder (MDD), ammoxetine is well tolerated and shows superior efficacy relative to placebo, as shown in a phase II study conducted in China.

Patients with psoriasis who are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have lower risks of mortality and adverse cardiovascular events, according to a retrospective study.

International healthcare workers deployed to Gaza, Palestine, report experiencing extensive polytrauma (≥2 anatomical regions), complex blast injuries from high yield explosives, firearm-related injuries to upper and lower limbs, and severe disruption to primary care and the treatment of chronic diseases during the ongoing conflict, results of a recent survey have shown.

Treatment with memantine may improve social functioning in children with autism spectrum disorder (ASD), as shown in a small study.